Free Trial

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Stock Position Lifted by Schroder Investment Management Group

Ryan Specialty logo with Finance background
Remove Ads

Schroder Investment Management Group lifted its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 2.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 742,571 shares of the company's stock after acquiring an additional 18,623 shares during the quarter. Schroder Investment Management Group owned about 0.28% of Ryan Specialty worth $47,317,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in RYAN. Rakuten Securities Inc. purchased a new stake in shares of Ryan Specialty in the fourth quarter worth about $27,000. Principal Securities Inc. lifted its position in Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock worth $43,000 after acquiring an additional 415 shares in the last quarter. Quarry LP boosted its holdings in Ryan Specialty by 109.3% in the 3rd quarter. Quarry LP now owns 808 shares of the company's stock worth $54,000 after acquiring an additional 422 shares during the period. Harvest Fund Management Co. Ltd acquired a new stake in Ryan Specialty in the fourth quarter valued at approximately $54,000. Finally, R Squared Ltd purchased a new stake in shares of Ryan Specialty during the fourth quarter valued at approximately $92,000. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty Stock Performance

NYSE:RYAN traded down $5.38 during trading hours on Friday, reaching $70.55. 1,434,020 shares of the stock were exchanged, compared to its average volume of 932,127. Ryan Specialty Holdings, Inc. has a 52 week low of $48.48 and a 52 week high of $77.16. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a market capitalization of $18.48 billion, a P/E ratio of 102.25, a P/E/G ratio of 1.19 and a beta of 0.66. The firm has a 50 day simple moving average of $69.60 and a 200-day simple moving average of $68.64.

Remove Ads

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). The business had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. As a group, sell-side analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend was Tuesday, March 4th. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio is currently 69.57%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Royal Bank of Canada decreased their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research note on Friday, February 21st. Keefe, Bruyette & Woods decreased their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a research report on Friday, February 21st. UBS Group lifted their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Finally, Wells Fargo & Company increased their price target on Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $75.27.

Get Our Latest Analysis on Ryan Specialty

Insiders Place Their Bets

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 29,466 shares of the stock in a transaction on Monday, January 13th. The stock was sold at an average price of $65.06, for a total value of $1,917,057.96. Following the sale, the director now directly owns 45,409 shares of the company's stock, valued at $2,954,309.54. This trade represents a 39.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders have sold 241,360 shares of company stock valued at $16,006,428 over the last quarter. Insiders own 11.10% of the company's stock.

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Further Reading

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility
MicroStrategy’s Bold Bitcoin Bet: Genius Move or Dangerous Gamble?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads